News

DENVER, Colo. — Smoking cessation among patients enrolled in a low-dose computed tomography screening program is associated with a three-to-five times reduction in mortality, according to research presented today at 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC) in Denver.

DENVER, Colo. – Adding the monoclonal antibody bevacizumab to chemotherapy treatment for patients with surgically removed non-small cell lung cancer did not improve overall survival, according to research presented today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC) in Denver.

DENVER, Colo. — Oncology researchers must “lace up our running shoes,” to keep up with the fast pace of lung cancer research, said Dr. David R. Gandara, Professor of Medicine, Division of Hematology/Oncology, director, Thoracic Oncology Program, Senior Advisor to the Director, UC Davis Comprehensive Cancer Center, Sacramento, Calif.

DENVER, Colo. — Researchers expect that the administration of molecular-targeted therapies will be considered for the advanced-stage of adenocarcinoma in young lung cancer patients, according to a presentation by Dr. Kosuke Tanaka, department of Cancer Genetics, Nagoya University Graduate School of Medicine; Division of Molecular Oncology, Aichi Cancer Center Research Institute, Japan. Dr. Tanaka presented his data at 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC) in Denver.

DENVER, Colo. — Research presented today shows that certain lung cancer patients under age 40 are associated with an increased chance for a targeted genomic alteration that may lead to more effective treatments. Dr. Barbara Gitlitz, Associate Professor of Clinical Medicine at the University of Southern California Keck School of Medicine in Los Angeles unveiled the findings at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. — The percentage of patients with non-small cell lung cancer (NSCLC) who never smoked is on the rise, according to a report conducted of lung cancer patients in three hospitals in Texas and Tennessee. Dr. Lorraine Pelosof, Assistant Professor, UT Southwestern Medical Center, Dallas, Texas presented the research at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

Pages